Beyond Medical Technologies Inc.
DOCT
CNSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -17.50% | -16.01% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.50% | -16.01% | |||
| Operating Income | 17.50% | 16.01% | |||
| Income Before Tax | 18.07% | -73.18% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 18.07% | -73.18% | |||
| Earnings from Discontinued Operations | -100.00% | -99.83% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 17.96% | -568.15% | |||
| EBIT | 17.50% | 16.01% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 18.28% | -565.00% | |||
| Normalized Basic EPS | 15.52% | 22.67% | |||
| EPS Diluted | 18.28% | -565.00% | |||
| Normalized Diluted EPS | 15.52% | 22.67% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||